Long-term KST
Previous Close | 18.77 |
Open | 18.79 |
Bid | 17.21 x 800 |
Ask | 18.95 x 800 |
Day's Range | 18.43 - 19.00 |
52 Week Range | 14.47 - 21.43 |
Volume | |
Avg. Volume | 4,288 |
Market Cap | 67.361M |
Beta (5Y Monthly) | 0.98 |
PE Ratio (TTM) | 15.08 |
EPS (TTM) | 1.26 |
Earnings Date | Aug 23, 2023 - Aug 28, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 27.00 |
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...
PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2023 third quarter ended March 31, 2023.
Pro-Dex (NASDAQ:PDEX) has had a rough three months with its share price down 10%. However, stock prices are usually...
Looking at Pro-Dex, Inc.'s ( NASDAQ:PDEX ) insider transactions over the last year, we can see that insiders were net...
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Phoenix, Arizona--(Newsfile Corp. - February 14, 2023) - The Stock Day Podcast welcomed Pro-Dex, Inc. (NASDAQ: PDEX) ("the Company"), a company that specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. CEO of the Company, Rick Van Kirk, joined Stock Day host Everett Jolly. Jolly began the interview by asking about the Company's
PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2023 second quarter ended December 31, 2022.
While Pro-Dex, Inc. ( NASDAQ:PDEX ) might not be the most widely known stock at the moment, it saw significant share...
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
With its stock down 11% over the past month, it is easy to disregard Pro-Dex (NASDAQ:PDEX). But if you pay close...
Pro-Dex ( NASDAQ:PDEX ) First Quarter 2023 Results Key Financial Results Revenue: US$11.1m (up 11% from 1Q 2022). Net...
PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2023 first quarter ended September 30, 2022.
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...
Phoenix, Arizona--(Newsfile Corp. - September 29, 2022) - The Stock Day Podcast welcomed Pro-Dex, Inc. (NASDAQ: PDEX) ("the Company"), a company that specializes in the design, development, and manufacture of autoclavable, battery-powered, and electric multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. CEO of the Company, Rick Van Kirk, joined Stock Day host Everett Jolly.Jolly began the interview by asking about the Company's
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...
PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2022 fourth quarter and full-year ended June 30, 2022.
While Pro-Dex, Inc. ( NASDAQ:PDEX ) might not be the most widely known stock at the moment, it received a lot of...
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
Pro-Dex (NASDAQ:PDEX) has had a rough three months with its share price down 3.2%. However, stock prices are usually...
Phoenix, Arizona--(Newsfile Corp. - June 6, 2022) - The Stock Day Podcast welcomed Pro-Dex, Inc. (NASDAQ: PDEX) ("the Company"), a company that specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. CEO of the Company, Richard Van Kirk, joined Stock Day host Sever Copley. Copley began the interview by asking about the Company's cu